Completed

STATETAPAT Program for Chronic Late-Life Insomnia in Older Adults

What is being tested

Computerized Plasticity-Based Adaptive Cognitive Training

+ Active Comparator

Other

Who is being recruted

Mental Disorders+3

+ Sleep Initiation and Maintenance Disorders

+ Nervous System Diseases

Over 55 Years

+8 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Treatment Study

Interventional

Study Start: July 2018

See protocol details

Summary

Principal SponsorPosit Science Corporation

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: July 10, 2018

Actual date on which the first participant was enrolled.

The study focuses on evaluating the acceptability of the Tonic and Phasic Alertness Training (TAPAT) program in older adults experiencing chronic late-life insomnia. This computerized attention-training program, TAPAT, is specifically designed to address chronic late-life insomnia. The importance of this study lies in its potential to validate the feasibility and initial effectiveness of this remote, controlled trial approach in this population.

Official TitleSTATE Trial: SusTained Attention Training to Enhance Sleep (Phase I- Remote Trial Arm)

NCT03604380

Principal SponsorPosit Science Corporation

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

134 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 55 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Mental DisordersSleep Initiation and Maintenance DisordersNervous System DiseasesSleep Wake DisordersSleep Disorders, IntrinsicDyssomnias

Criteria

5 inclusion criteria required to participate

Participant must be 55 years of age or older.

Participant must meet criteria for clinical insomnia - moderate severity based on the Insomnia Severity Index.

Participant must be a fluent English speaker.

Participant must have adequate visual, auditory, and motor capacity to use computerized intervention.

Show More Criteria

3 exclusion criteria prevent from participating

Participants with untreated psychiatric conditions, including substance abuse/dependence disorders, untreated obstructive sleep apnea, diagnosis of other sleep disorders (e.g., restless legs syndrome), recent hospitalization, ongoing chemotherapy or other cancer treatment, and concurrent engagement in another insomnia treatment.

Participants enrolled in another concurrent research study.

Participants using computer-based cognitive training programs or has used them within a month of the consent date.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Treatment Groups

Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group

Treatment Groups

Group I

Experimental

Computerized plasticity-based adaptive cognitive training requiring a total maximum of 36 treatment sessions, up to 7 sessions per week, 36 minutes per session.

Group II

Active Comparator

Commercially available computerized training requiring a total maximum of 36 treatment sessions, up to 7 sessions per week, 36 minutes per session.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Posit Science Corporation

San Francisco, United StatesOpen Posit Science Corporation in Google Maps

CompletedOne Study Center